NO984075L - Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn - Google Patents

Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn

Info

Publication number
NO984075L
NO984075L NO984075A NO984075A NO984075L NO 984075 L NO984075 L NO 984075L NO 984075 A NO984075 A NO 984075A NO 984075 A NO984075 A NO 984075A NO 984075 L NO984075 L NO 984075L
Authority
NO
Norway
Prior art keywords
combination
medicament
dehydroepiandrosterone
men
relative
Prior art date
Application number
NO984075A
Other languages
English (en)
Other versions
NO984075D0 (no
Inventor
J Rg Elliesen
Albert Radlmaier
Ursula Habenicht
Friedmund Neumann
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO984075D0 publication Critical patent/NO984075D0/no
Publication of NO984075L publication Critical patent/NO984075L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
NO984075A 1996-03-06 1998-09-04 Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn NO984075L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19610645A DE19610645A1 (de) 1996-03-06 1996-03-06 Kombination von Dehydroepiandrosteron und Aromatasehemmern und Verwendung dieser Kombination zur Herstellung eines Arzeimittels zur Behandlung eines relativen und absoluten Androgenmangels beim Mann
PCT/DE1997/000518 WO1997032588A2 (de) 1996-03-06 1997-03-06 Kombination von dehydroepiandrosteron und aromatasehemmern und verwendung dieser kombination zur herstellung eines arzneimittels zur behandlung eines relativen und absoluten androgenmangels beim mann

Publications (2)

Publication Number Publication Date
NO984075D0 NO984075D0 (no) 1998-09-04
NO984075L true NO984075L (no) 1998-09-04

Family

ID=7788665

Family Applications (1)

Application Number Title Priority Date Filing Date
NO984075A NO984075L (no) 1996-03-06 1998-09-04 Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn

Country Status (18)

Country Link
US (1) US6696432B1 (no)
EP (1) EP0885005B1 (no)
JP (1) JP2000506844A (no)
KR (1) KR19990087573A (no)
AT (1) ATE247968T1 (no)
AU (1) AU730777B2 (no)
BR (1) BR9707844A (no)
CA (1) CA2248251A1 (no)
DE (2) DE19610645A1 (no)
DK (1) DK0885005T3 (no)
ES (1) ES2206706T3 (no)
HU (1) HUP9901505A3 (no)
IL (1) IL125821A0 (no)
NO (1) NO984075L (no)
PL (1) PL328709A1 (no)
PT (1) PT885005E (no)
WO (1) WO1997032588A2 (no)
ZA (1) ZA971965B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1322333A2 (en) * 2000-08-09 2003-07-02 Pharmacia Italia S.p.A. Composition for combined use of aromatase inhibitors
WO2003017974A1 (en) * 2001-08-31 2003-03-06 Pantarhei Bioscience B.V. Method of treating benign gynaecological disorders and a pharmaceutical kit for use in such method
AU2003213957A1 (en) * 2002-04-03 2003-10-13 Jencap Research Ltd. Pharmaceutical composition comprising an aromatase inhibitor and an estrogen suitable for hormone replacement therapy for a male
AU2006303878B2 (en) * 2005-10-19 2011-10-20 Havah Therapeutics Pty Ltd Reduction of side effects from aromatase inhibitors used for treating breast cancer
CA2626337C (en) * 2005-10-19 2015-12-29 Chavah Pty Ltd Reduction of side effects from aromatase inhibitors used for treating breast cancer
AU2012200290B2 (en) * 2005-10-19 2014-08-21 Havah Therapeutics Pty Ltd Reduction of side effects from aromatase inhibitors used for treating breast cancer
US7874032B2 (en) * 2008-06-24 2011-01-25 Vaughn North Method and device for maintaining a side sleeping position
US9744177B2 (en) * 2014-03-10 2017-08-29 Endorecherche, Inc. Treatment of male androgen deficiency symptoms or diseases with sex steroid precursor combined with SERM
US10213440B2 (en) 2014-08-20 2019-02-26 Professional Compounding Centers Of America (Pcca) Oral transmucosal pharmaceutical compositions including testosterone and an aromatase inhibitor
CA2965372C (en) 2014-10-22 2023-09-05 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
CA3002562A1 (en) 2015-10-22 2017-04-27 Havah Therapeutics Pty Ltd Methods of reducing mammographic breast density and/or breast cancer risk
CN114599369B (zh) 2019-06-03 2026-02-10 哈瓦赫治疗有限公司 用于递送雄激素剂和芳香酶抑制剂的药物制剂和系统以及使用方法
CN115554403B (zh) * 2022-08-16 2024-03-08 山东大学 类固醇激素dhea作为受体adgrg2激动剂配体的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4835147A (en) 1987-05-06 1989-05-30 City Of Hope Dehydroepiandrosterone therapy for ameleoration of prostate hypertrophy and sexual dysfunction
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
DK0595796T3 (da) * 1989-07-07 2003-05-05 Endorech Inc Fremgangsmåde til behandling af androgen-relaterede sygdomme
HU221191B1 (en) * 1992-09-30 2002-08-28 Teikoku Hormone Mfg Co Ltd 7-substituted oxasteroid compounds, process for their preparation and pharmaceutical compositions containing the same
DE4435368A1 (de) 1994-09-22 1996-03-28 Schering Ag Verwendung von Aromatasehemmern zur Herstellung eines Arzneimittels zur Behandlung eines relativen Androgenmangels beim Mann

Also Published As

Publication number Publication date
WO1997032588A2 (de) 1997-09-12
IL125821A0 (en) 1999-04-11
ATE247968T1 (de) 2003-09-15
HUP9901505A3 (en) 2000-05-29
AU730777B2 (en) 2001-03-15
NO984075D0 (no) 1998-09-04
AU2690297A (en) 1997-09-22
ZA971965B (en) 1997-09-10
PT885005E (pt) 2004-01-30
EP0885005B1 (de) 2003-08-27
DE19610645A1 (de) 1997-09-11
CA2248251A1 (en) 1997-09-12
BR9707844A (pt) 1999-07-27
DK0885005T3 (da) 2003-12-15
ES2206706T3 (es) 2004-05-16
DE59710660D1 (de) 2003-10-02
WO1997032588A3 (de) 1997-10-16
US6696432B1 (en) 2004-02-24
JP2000506844A (ja) 2000-06-06
KR19990087573A (ko) 1999-12-27
PL328709A1 (en) 1999-02-15
EP0885005A2 (de) 1998-12-23
HUP9901505A2 (hu) 1999-09-28

Similar Documents

Publication Publication Date Title
IL132797A0 (en) Compounds and methods for the inhibition of the expression of vcam-1
NO984075D0 (no) Kombinasjon av dehydroepiandrosteron og aromatasehemmere og anvendelse av denne kombinasjon for fremstilling av et legemiddel for behandling av en relativ og absolutt androgen mangel hos menn
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
ATE208210T1 (de) Kombination von proteintyrosin-kinaseinhibitoren und chemischer kastration zur behandlung von prostatakrebs
MY106484A (en) Combination therapy for phophylaxis and/or treatment of benign prostatic hyperplasia.
BG104780A (en) Inhibitors of phospholipase enzymes
UA35589C2 (uk) ІНГІБІТОРИ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ ТА СПОСІБ ІНГІБУВАННЯ АКТИВНОСТІ ТЕСТОСТЕРОН 5-<font face="Symbol">a</font>-РЕДУКТАЗИ
PL328858A1 (en) Immunogenous peptides
WO1998033491A3 (en) Treatment of arrhythmias via inhibition of a multifunctional calcium/calmodulin-dependent protein kinase
IL110943A (en) Compositions comprising an inhibitor of cholesterol synthesis for the treatment of skin disorders
EP0646007A4 (no)
IL152097A0 (en) Use of pyrazole derivatives for treating infertility
ATE283044T1 (de) Compactin zur behandlung von entzündungen
MXPA02000330A (es) Pirrolidinas y piperidinas neurotroficas y composiciones y metodos relacionados.
AU6083301A (en) Treating eczema and/or psoriasis
IL144199A0 (en) Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
MXPA05008347A (es) Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis.
NO952601L (no) Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser
AU2576901A (en) Agents and methods for the treatment of proliferative diseases
WO2003041640A3 (en) METHODS FOR TREATING ISCHEMIC REPERFUSION INJURY USING IkB KINASE-BETA INHIBITORS
AU1047002A (en) 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds
AU2003282035A1 (en) Modulation of s6 kinase activity for the treatment of obestiy
AU2001262378A1 (en) Method for treating cryptorchidism
IL129900A0 (en) Budenoside for the treatment of cholestatic liver diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application